Neurol. praxi. 2009;10(5):324-327

Low-grade glioma (fibrilary astrocytoma) and epilepsy

MUDr. Jana Zárubová
Neurologická klinika IPVZ, Fakultní Thomayerova nemocnice Praha

Patients with low grade glioma and symptomatic focal epilepsy represent a complicated clinical problem. A case report of now 37

years old female successfully treated with temozolomid is presented here. She had her first secondarily generalized epileptic seizure

in postpartum period. MRI discovered low grade glioma in the right parietal region. Her epilepsy soon proved refractory to treatment.

Because of epilepsy farmacoresistancy and tumor growth on MRI neurosurgery was indicated. Only partial resection was done due to

risk of permanent motor deficit. Histopathology exam diagnosed fibrilary astrocytoma WHO II. Further growth of the tumor was noted

on MRI three years later. The choise of temozolomid as most suitable treatment was based on thorough interdisciplinary discussion

including assesing the risks of alternative treatments, neurosurgery and radiotherapy. After 12 month of treatment with temozolomid

the tumor ceased to grow and remains unchanged in size for four years. Epilepsy is reasonably controled without change in medication.

Treatment with temozolomid is not a standard option in treatment of low grade gliomas. An overview of data on this issue available in

the literature is presented here for discussion.

Keywords: low-grade glioma, fibrillary astrocytoma, symptomatic focal epilepsy, temozolomide.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zárubová J. Low-grade glioma (fibrilary astrocytoma) and epilepsy. Neurol. praxi. 2009;10(5):324-327.
Download citation

References

  1. Duffau H. Surgery of low-grade gliomas: towards a, ,functional neurooncology" Curr Opin Oncol 2009 Jul 13, (Epub ahead of print). Go to original source... Go to PubMed...
  2. Duffau H. Contribution of cortical and subcortical electrostimulation in brain glioma surgery: methodological and functional considerations. Neurophysiol Clin 2007; 37(6): 373-382. Go to original source... Go to PubMed...
  3. Duffau H. New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity-a review. J Neurooncol 2006; 79(1): 77-115. Go to original source... Go to PubMed...
  4. Hilkman DMW, De Krom MCTFM, Twijnstra A. Chemotherapy for refractory epilepsy. Poster on IEC, Budapest; 2009.
  5. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008; 108(2): 227-235. Go to original source... Go to PubMed...
  6. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crini?re E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Bro?t P, Sanson M, Delattre JY. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol. 2004; 22(15): 3133-3138. Go to original source... Go to PubMed...
  7. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, HoangXuan K. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007; 68(21): 1831-1836. Go to original source... Go to PubMed...
  8. Kozler P, Kramář F. Nádory CNS - léčebné modality. Převzato z Kolektiv autorů, Neurologie 2005. Praha: Triton 2005. http://www.tridistri.cz. Dostupné na Medicabaze - lékařské repetitorium online, http://www.medicabaze.cz/index.php.
  9. Kramář F, Zemanová Z, Michalová K a spol. Patogeneze mozkových gliomů, I. část. Úvod do problematiky, patogeneze astrocytárních nádorů. Čes a slov. Neurol. Neurochir. 2006; 69/102(5): 346-354.
  10. Liu R, Solheim K, Polley MY, Lamborn KR, Page M, Fedoroff A, Rabbitt J, Butowski N, Prados M, Chang SM. Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol 2009; 11(1): 59-68. Go to original source... Go to PubMed...
  11. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quino?es-Hinojosa A. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008; 63: 700-707. Go to original source... Go to PubMed...
  12. Mraček J, Choc M, Hes O, Vaněček T. Současná diagnostika a léčba oligodendrogliomů. Cesk Slov Neurol N. 2008; 71/104(5): 537-543.
  13. Nagasubramanian R, Dolan ME. Temozolomid: realizing the promise and potential. Curr Opin Oncol. 2003; 15(6): 412-418. Go to original source... Go to PubMed...
  14. Pace A, Vidiri A, Gali? E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003; 14(12): 1722-1726. Go to original source... Go to PubMed...
  15. Radhakrishnan A, Sithinamsuwan P, Harvey AS, Flanagan D, Fitt G, Berlangieri S, Jackson GD, Berkovic SF, Scheffer IE. Multifocal epilepsy: the role of palliative resection - intractable frontal and occipital lobe epilepsy secondary to radiotherapy for acute lymphoblastic leukaemia. Epileptic Disord. 2008; 10(4): 362-370. Go to PubMed...
  16. Rezvan A, Christine D, Christian H, Olga Z, Lutz E, Marius H, Stephanie C, Christel HM, Rainer WC, Andreas U. Long-term outcome and survival of surgically treated supratentorial lowgrade glioma in adult patients. Acta Neurochir (Wien). 2009; 3. Epub ahead of print. Go to original source... Go to PubMed...
  17. Salmaggi A, Fariselli L, Milanesi I, Lamperti E, Silvani A, Bizzi A, Maccagnano E, Trevisan E, Laguzzi E, Ruda R, Boiardi A, Soffietti R; Associezione Italiana di Neuro-oncologica. Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol. 2008; 255(2): 171-177. Go to original source... Go to PubMed...
  18. Sanai N, Berger MS. Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics. 2009; 6(3): 478-486. Go to original source... Go to PubMed...
  19. Tosoni A, Franceschi E, Ermani M, Bertorelle R, Bonaldi L, Blatt V, Brandes AA. Temozolomid three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas. J Neurooncol. 2008; 89(2): 179-185. Go to original source... Go to PubMed...
  20. Van den Bent MJ. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. Semin Oncol. 2003; 30(6 Suppl 19): 39-44. Go to original source... Go to PubMed...
  21. Wen PY, DeAngelis LM. Chemotherapy for low-grade gliomas. Neurology 2007; 68: 1762-1663. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.